Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells

被引：0
|
作者：
Breckpot, K. [1 ]
Pen, J. J. [1 ]
De Keersmaecker, B. [1 ]
Heirman, C. [1 ]
Corthals, J. [1 ]
Liechtenstein, T. [1 ,2 ]
Escors, D. [2 ,3 ]
Thielemans, K. [1 ]
机构：
[1] Vrije Univ Brussel, Lab Mol & Cellular Therapy, Dept Immunol Physiol, Brussels, Belgium
[2] UCL, Div Infect & Immun, Rayne Inst, London, England
[3] Navarrabiomed FMS, Pamplona, Spain
来源：
HUMAN GENE THERAPY | 2013年 / 24卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A166 / A167
页数：2
相关论文
共 50 条
  • [1] Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells
    J J Pen
    B D Keersmaecker
    C Heirman
    J Corthals
    T Liechtenstein
    D Escors
    K Thielemans
    K Breckpot
    Gene Therapy, 2014, 21 : 262 - 271
  • [2] Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells
    Pen, J. J.
    Keersmaecker, B. D.
    Heirman, C.
    Corthals, J.
    Liechtenstein, T.
    Escors, D.
    Thielemans, K.
    Breckpot, K.
    GENE THERAPY, 2014, 21 (03) : 262 - 271
  • [3] Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
    Chunyi Shen
    Zhen Zhang
    Yonggui Tian
    Feng Li
    Lingxiao Zhou
    Wenyi Jiang
    Li Yang
    Bin Zhang
    Liping Wang
    Yi Zhang
    BMC Medicine, 19
  • [4] PD-L1 on Antigen-Presenting Cells Facilitate the Induction of Antigen-Specific Cytotoxic T Lymphocytes
    Goto, Tatsunori
    Nishida, Tetsuya
    Takagi, Erina
    Miyao, Kotaro
    Koyama, Daisuke
    Sakemura, Reona
    Hanajiri, Ryo
    Watanabe, Keisuke
    Imahashi, Nobuhiko
    Terakura, Seitaro
    Murata, Makoto
    Kiyoi, Hitoshi
    BLOOD, 2015, 126 (23)
  • [5] Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
    Shen, Chunyi
    Zhang, Zhen
    Tian, Yonggui
    Li, Feng
    Zhou, Lingxiao
    Jiang, Wenyi
    Yang, Li
    Zhang, Bin
    Wang, Liping
    Zhang, Yi
    BMC MEDICINE, 2021, 19 (01)
  • [6] PD-1/PD-L1 interactions contribute to functional impairment of minor histocompatibility antigen-specific CD8+T-cells targeting PD-L1-expressing leukaemic cells
    Norde, W. J.
    Maas, F.
    Korman, A.
    Quigley, M.
    Kester, M.
    Hebeda, K.
    Falkenburg, J. H. F.
    de Witte, T.
    Schaap, N.
    van der Voort, R.
    Dolstra, H.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S310 - S310
  • [7] Tumor Endothelial Cell-Mediated Antigen-Specific T-cell Suppression via the PD-1/PD-L1 Pathway
    Taguchi, Kazuhiro
    Onoe, Takashi
    Yoshida, Tomoaki
    Yamashita, Yoshinori
    Tanaka, Yuka
    Ohdan, Hideki
    MOLECULAR CANCER RESEARCH, 2020, 18 (09) : 1427 - 1440
  • [8] Tumor endothelial cell-mediated antigen-specific T-cell suppression via the PD-1/PD-L1 pathway
    Taguchi, Kazuhiro
    Onoe, Takashi
    Tashiro, Hirotaka
    Ohdan, Hideki
    CANCER SCIENCE, 2021, 112 : 402 - 402
  • [9] Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes
    Afroj, Tania
    Mitsuhashi, Atsushi
    Ogino, Hirokazu
    Saijo, Atsuro
    Otsuka, Kenji
    Yoneda, Hiroto
    Tobiume, Makoto
    Na Thi Nguyen
    Goto, Hisatsugu
    Koyama, Kazuya
    Sugimoto, Masamichi
    Kondoh, Osamu
    Nokihara, Hiroshi
    Nishioka, Yasuhiko
    JOURNAL OF IMMUNOLOGY, 2021, 206 (06): : 1204 - 1214
  • [10] Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responses
    Rekoske, Brian T.
    Olson, Brian M.
    McNeel, Douglas G.
    ONCOIMMUNOLOGY, 2016, 5 (06):
12345